Cytek Biosciences, Inc. (NASDAQ:CTKB)
Insiders here have filed 25 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $206.7M
- Net income
- -$80.6M
- Net margin
- -39.0%
Little or no net debt.
- Total debt
- $26.5M
- Cash
- $73.8M
- Debt / equity
- 0.08
Comfortably covers what is due within a year.
- Current assets
- $377.9M
- Current liabilities
- $84.3M
- Current ratio
- 4.48
Roughly cash-neutral.
- Operating cash flow
- -$6.0M
- Free cash flow
- -$12.1M
- FCF margin
- -5.8%
Not funding itself by issuing shares.
- Shares outstanding
- 129.5M
- Share growth (1y)
- 2.0%
- Cash runway
- 147 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CTKB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 48.14 M | 44.13 M | 62.14 M | 52.29 M | 45.60 M | 41.46 M |
| Revenue Growth (YoY) | 5.57 % | 6.46 % | 8.12 % | 1.54 % | -2.18 % | -7.59 % |
| Cost of Revenue | 19.80 M | 22.88 M | 29.26 M | 24.74 M | 21.73 M | 21.30 M |
| Gross Profit | 28.34 M | 21.25 M | 32.88 M | 27.55 M | 23.87 M | 20.16 M |
| SG&A Expense | 30.00 M | 30.11 M | 29.52 M | 27.79 M | 25.66 M | 25.41 M |
| R&D Expense | 9.74 M | 9.60 M | 8.96 M | 8.96 M | 8.83 M | 9.72 M |
| Operating Expenses | 39.74 M | 39.72 M | 38.48 M | 36.74 M | 34.49 M | 35.13 M |
| Operating Income | -11.40 M | -18.46 M | -5.59 M | -9.19 M | -10.62 M | -14.97 M |
| Pretax Income | -11.64 M | -17.37 M | -4.03 M | -7.77 M | -6.78 M | -11.27 M |
| Tax Provision | 515.00 K | 1.49 M | 40.05 M | -2.29 M | -1.19 M | 136.00 K |
| Net Income | -12.16 M | -18.87 M | -44.08 M | -5.48 M | -5.58 M | -11.40 M |
| EPS (Basic) | -0.09 | -0.15 | -0.34 | -0.04 | -0.04 | -0.09 |
| EPS (Diluted) | -0.09 | -0.15 | -0.34 | -0.04 | -0.04 | -0.09 |
| Shares Outstanding | 129.46 M | 128.70 M | 128.17 M | 127.55 M | 126.93 M | 128.34 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.